At UChicago Medicine, the bariatric surgery journey is personalized
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist: A phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
Never inject the same spot on consecutive weeks
The capsules have no taste and go down smoothly, which is a relief
This synthetic version of the natural hormone glucagon-like peptide-1 (GLP-1) has the dual advantage of regulating blood sugar levels and promoting weight loss
For example: If your hormones are contributing to weight gain, blood testing can identify the issue If you have obesity-related risk factors, your doctor can monitor and treat them If medication is appropriate, GLP-1s like Wegovy can regulate appetite and insulin response Combined with a personalised nutrition and activity plan, this approach supports safe, steady progress without extreme dieting